Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

 
    
            

View in Other Languages

News

Bluechiip Ltd (ASX:BCT) Quarterly Activity - Cashflow Report

🕔1/29/2021 8:44:59 AM 2010

Bluechiip Ltd (ASX:BCT) sales and marketing teams both in Australia and the United States continue to make progressive negotiations with potential OEMs especially in the IVF and Cell Therapy markets despite current COVID-19 travel restrictions.

Read Full Article

Bluechiip Ltd (ASX:BCT) Annual General Meeting - CEO's Presentation

🕔11/27/2020 8:46:43 AM 2926

Bluechiip Ltd (ASX:BCT) has a world first, highly differentiated technology, with protected IP and a $200M growing target market, with very large adjacent markets.

Read Full Article

Bluechiip Ltd (ASX:BCT) Lodgement of Open Briefing

🕔11/6/2020 8:22:03 AM 3613

Lodgement of Open Briefing with Managing Director, Andrew McLellan: Bluechiip's (ASX:BCT) results for Q1FY21, pipeline developments and direct to market strategy.

Read Full Article

Bluechiip Ltd (ASX:BCT) Quarterly Report

🕔10/29/2020 6:24:19 PM 2211

Bluechiip Limited (ASX:BCT) today released its quarterly cash flow report for the quarter ended 30 September 2020.

Read Full Article

Bluechiip Ltd (ASX:BCT) Lodgement of Open Briefing

🕔9/2/2020 8:19:43 AM 2214

In this Open Briefing(R), Managing Director, Andrew McLellan discusses Bluechiip's (ASX:BCT) 2020 financial results, the Annual Report and the outlook for 2021.

Read Full Article

Bluechiip Ltd (ASX:BCT) Appendix 4E and Annual Report

🕔8/27/2020 4:50:10 PM 2402

The Group reported a consolidated loss after providing for income tax for the financial year ended 30 June 2020 of $4,501,085, compared to a consolidated loss of $3,257,996 for the financial year ended 30 June 2019.

Read Full Article

Bluechiip Ltd (ASX:BCT) Quarterly Report

🕔7/28/2020 10:35:22 AM 2137

Bluechiip Limited (ASX:BCT) today released its quarterly cash flow report for the quarter ended 30 June 2020.

Read Full Article

Bluechiip Ltd (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔7/21/2020 9:01:56 AM 2160

Bluechiip Ltd (ASX:BCT) Managing Director, Andrew McLellan on Labcon's purported termination of chip supply agreement and Bluechiip's market opportunities.

Read Full Article

Bluechiip Ltd (ASX:BCT) Labcon Purports to Terminate Chip Supply Agreement

🕔7/16/2020 10:28:50 AM 2760

Bluechiip Limited (ASX:BCT) a leader in the development of sample-tracking technology for harsh environments, today announced that key customer Labcon North America has provided notice to Bluechiip purporting to terminate the chip supply agreement it has with Bluechiip.

Read Full Article

Bluechiip Ltd (ASX:BCT) Lodgment of Open Briefing

🕔4/28/2020 8:30:58 AM 2313

Bluechiip Ltd (ASX:BCT) Managing Director, Andrew McLellan on Bluechiip response to COVID 19 crisis, operations and outlook in the March quarter.

Read Full Article
###

108,843 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 161) (Last 30 Days: 820) (Since Published: 71359) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports

More News Results

  • 2024/05/14: BCT Partners with Biopharma Group to Distribute in the UK*
  • 2024/04/30: Open Briefing*
  • 2024/04/30: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/04/16: Change of Director's Interest Notice - AM*
  • 2024/04/16: Notification of cessation of securities - BCT*
  • 2024/04/16: Notification regarding unquoted securities - BCT*
  • 2024/03/18: Change of Director's Interest Notice - AC*
  • 2024/03/18: Change of Director's Interest Notice - AM*
  • 2024/03/18: Becoming a substantial holder*
  • 2024/03/18: Change of Director's Interest Notice - IK*
*refer to company website

Presentations

Download Presentation

Research Report

Download Presentation

Quarterly Report

Download Presentation

Social Media